Targeting endothelial and tumor cells with semaphorins

Area of Science:

• Molecular Biology
• Developmental Biology
• Cancer Biology

Background:

• Neuropilins (NRP) are receptors for class 3 semaphorins (SEMA3) and vascular endothelial growth factor (VEGF).
• Initially identified for roles in axon guidance, NRPs and SEMA3s are now recognized for their critical functions in vascular and tumor biology.
• Molecular mechanisms regulating neuronal guidance and angiogenesis share similarities.

Purpose of the Study:

• To review structural interactions between NRPs and SEMA3s.
• To examine the roles of NRPs and SEMA3s in developmental and tumor angiogenesis.
• To explore their involvement in tumor metastasis.

Main Methods:

• Review of cell culture, zebrafish, and murine studies.
• Analysis of structural interactions between NRP and SEMA3 proteins.
• Evaluation of preclinical data on SEMA3F and anti-NRP1 antibodies.

Main Results:

• SEMA3s exhibit similar effects on neurons, endothelial cells, and tumor cells, repelling growth and collapsing structures.
• SEMA3F demonstrates potent inhibition of tumor angiogenesis and metastasis in preclinical models.
• Neutralizing antibodies against NRP1 potentiate the anti-tumor effects of anti-VEGF antibodies in xenografts.

Conclusions:

• NRPs and SEMA3s are key regulators of both angiogenesis and metastasis.
• Targeting the NRP/SEMA3 pathway holds therapeutic potential for cancer treatment.
• Combined therapies, such as anti-NRP1 and anti-VEGF antibodies, show promise in suppressing tumor growth.